Work

Bortezomib, Lenalidomide and Dexamethasone Vs. Lenalidomide and Dexamethasone in Patients (Pts) with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant (ASCT): Results of the Randomized Phase III Trial SWOG S0777

Year: 2015

Type: article

Source: Blood

DOI: 10.1182/blood.v126.23.25.25

Authors: Brian Durie, Antje Hoering, S. Vincent Rajkumar, Muneer H. Abidi, Joshua Epstein, Stephen P. Kahanic, Mohan C. Thakuri, Frederic J Reu, Christopher M. Reynolds, Rachael Sexton, Robert Z. Orlowski, Bart Barlogie, Angela Dispenzieri

Institutions: International Myeloma Foundation, Mayo Clinic, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Arkansas for Medical Sciences, June E. Nylen Cancer Center, Southeast Clinical Oncology Research Consortium, Cancer Care of Western North Carolina, Cleveland Clinic, Trinity Health Ann Arbor Hospital, Michigan Cancer Research Consortium, Cancer Research And Biostatistics, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2477001395

FWCI: 12.32

Cites:

Cited by: 56

Related to: 10